Patent Assignment
Reel/Frame 015619/0485
Assignment of Assignor's Interest
Recorded: 2005-01-28
Pages: 3
Assignor
HAR-NOY, MICHAEL
Executed: 2005-01-20
Assignee
IMMUNOVATIVE THERAPIES, LTD.
MISGAV TECHNOLOGY CENTER, M.P. MISGAV, 20179, ISRAEL
Covered Properties
(7)
Compositions for Allogeneic Cell Therapy
Allogeneic CD4+ cell therapy
Application:
60/470,171 →
Biodegradable T-cell activation device and methods
Application:
60/545,450 →
Methods for preparing T-cells for cell therapy
Application:
60/547,966 →
Cell therapy formulation method and composition
Application:
60/549,032 →
Allogeneic cellular immunotherapy for invasive pulmonary aspergillosis (IPA)
Application:
60/618,682 →
Allogeneic Cell Therapy: Mirror Effect
PCT:
PCT/US2004/014589 ↗
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Rescission
Sep 12, 2019
From: HAR-NOY, MICHAEL
To: HAR-NOY, MICHAEL
Reel/Frame 050467/0081 →
Assignment of Assignor's Interest
Sep 25, 2019
From: IMMUNOVATIVE THERAPIES, LTD.
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050489/0245 →
Corrective Assignment to Correct the Assignor's Name from Immunovative Therapies, Ltd. to Michael Har-Noy on the Original Cover Sheet Previously Recorded on Reel 050489 Frame 0245. Assignor(S) Hereby Confirms the Assignment.
Oct 2, 2019
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050610/0633 →
Corrective Assignment to Correct the Correct the Address Os the Assignee Previously Recorded at Reel: 050489 Frame: 0245. Assignor(S) Hereby Confirms the Assignment.
Jan 28, 2020
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 052915/0513 →